Global Transmucosal Drug Delivery Devices Market Size Is Anticipated to Exceed USD 68.1 Billion by 2030 at a 6.2% CAGR

[209 + Pages Report] According to a market research study published by Zion Market Research, the demand analysis of Global Transmucosal Drug Delivery Devices Market size & share revenue was valued at around USD 41.2 billion in 2022 and is estimated to grow about USD 68.1 billion by 2030, at a CAGR of approximately 6.2% between 2023 and 2030. The key market players are listed in the report with their sales, revenues and strategies are Abbott, Bayer AG, Teva Pharmaceutical Industries Ltd., Slan Medicinal Holdings LTD, MMB Healthcare LLC., BioDelivery Sciences International Inc., Mylan N.V., Novartis AG, Bristol-Myers Squibb Company, Johnson & Johnson Private Limited, Antares Pharma, BD, 3M, Pfizer Inc., Boehringer Ingelheim International GmbH, Endo International plc, Echo Pharmaceuticals B.V., B. Braun Melsungen AG, Baxter, GlaxoSmithKline plc, and Acrux Limited among others.


New York, NY, Aug. 08, 2023 (GLOBE NEWSWIRE) -- Zion Market Research has published a new research report titled “Transmucosal Drug Delivery Devices Market By Product Type (Buccal Route, Rectal Route, And Nasal Route), By Application (Hospital And Residential) And By Region - Global And Regional Industry Overview, Market Intelligence, Comprehensive Analysis, Historical Data, And Forecasts 2023 – 2030” in its research database.

“According to the latest research study, the demand of global Transmucosal Drug Delivery Devices Market size & share in terms of revenue was valued at USD 41.2 billion in 2022 and it is expected to surpass around USD 68.1 billion mark by 2030, growing at a compound annual growth rate (CAGR) of approximately 6.2% during the forecast period 2023 to 2030.”

What are Transmucosal Drug Delivery Devices? How big is the Transmucosal Drug Delivery Devices Industry?

Report Overview:

The global Transmucosal Drug Delivery Devices Market size was worth around USD 41.2 billion in 2022 and is predicted to grow to around USD 68.1 billion by 2030 with a compound annual growth rate (CAGR) of roughly 6.5% between 2023 and 2030.

Transdermal drug delivery systems are an alternative to oral intravascular, subcutaneous, and transmucosal routes of drug administration. These devices transport medications through the skin for therapeutic purposes. The transmucosal drug delivery system has various benefits over the traditional methods of drug administration, which makes it an attractive option for enterprises that are a part of its value chain. One of the most significant benefits of transmucosal drug delivery is that it is possible to sidestep the natural defence mechanisms that are present in the body. It is projected that the market for transmucosal drug delivery devices would grow in the years to come as a result of the presence of a huge target market that will require regular drug delivery devices for the purposes of diagnosis and treatment.

Get a Free Sample PDF of this Research Report for more Insights with a Table of Content, Research Methodology, and Graphs - https://www.zionmarketresearch.com/sample/transmucosal-drug-delivery-devices-market

(A free sample of this report is available upon request; please contact us for more information.)

Our Free Sample Report Consists of the Following:

  • Introduction, Overview, and in-depth industry analysis are all included in the 2023 updated report.
  • The COVID-19 Pandemic Outbreak Impact Analysis is included in the package
  • About 209+ Pages Research Report (Including Recent Research)
  • Provide detailed chapter-by-chapter guidance on Request
  • Updated Regional Analysis with Graphical Representation of Size, Share, and Trends for the Year 2023
  • Includes Tables and figures have been updated
  • The most recent version of the report includes the Top Market Players, their Business Strategies, Sales Volume, and Revenue Analysis
  • Zion Market Research research methodology

(Please note that the sample of this report has been modified to include the COVID-19 impact study prior to delivery.)

Global Transmucosal Drug Delivery Devices Market: Growth Factors

The expansion of the market is being driven by the rising incidence of chronic diseases.

Over the course of the forthcoming time frame, the global market for transmucosal drug delivery devices is anticipated to be propelled forward by the rising incidence of chronic disorders such as cancer, cardiovascular disease, and diabetes, amongst others. For instance, according to the statistics that was provided by Cancer Research UK, there would be 28 million new instances of cancer diagnosed around the world each year by the year 2040 if incidence rates remain unchanged while population growth and ageing continue at the same rates as they are now.

This is a growth of 54.9% in comparison to the year 2020, and it is anticipated that the increase will be greater in males (60.6% growth) than in females (48.8% growth). In a similar vein, the National Institute of Health estimates that diabetes will affect 9.3% (463 million people) of the world's population in 2019. This percentage is projected to rise to 10.2% (578 million) by 2030 and 10.9% (700 million) by 2045. The incidence is higher in urban areas (10.8%) than it is in rural areas (7.2%), and it is higher in countries with high incomes (10.4%) than it is in countries with low incomes (4.0%). Therefore, the aforementioned characteristics lend assistance to the expansion of market revenue.

The market expansion is hindered by regulatory restrictions and a lack of pharmacological compatibility.

The process of developing and obtaining a license for transmucosal medicine delivery devices can be difficult and time consuming because of the stringent regulatory standards that must be met. It may be challenging for businesses operating in the transmucosal medication delivery devices sector to satisfy the standards of a large number of health authorities while simultaneously assuring their products' safety and effectiveness.

In addition, there is a possibility that transmucosal drug administration devices are not suitable for all prescribed medications. It's possible that some medications aren't designed to be absorbed through mucosal membranes, or that they might irritate or damage tissues, which would prevent them from being used in conjunction with these delivery systems. As a result, it is anticipated that this will serve as a significant barrier to the expansion of the market during the course of the time included in the forecast.

Directly Purchase a copy of the report with TOC @ https://www.zionmarketresearch.com/buynow/su/transmucosal-drug-delivery-devices-market

Report Scope

Report AttributeDetails
Market Size in 2022USD 41.2 billion
Projected Market Size in 2030USD 68.1 billion
CAGR Growth Rate6.2% CAGR
Base Year2022
Forecast Years2023-2030
Key Market PlayersAbbott, Bayer AG, Teva Pharmaceutical Industries Ltd., Slan Medicinal Holdings LTD, MMB Healthcare LLC., BioDelivery Sciences International Inc., Mylan N.V., Novartis AG, Bristol-Myers Squibb Company, Johnson & Johnson Private Limited, Antares Pharma, BD, 3M, Pfizer Inc., Boehringer Ingelheim International GmbH, Endo International plc, Echo Pharmaceuticals B.V., B. Braun Melsungen AG, Baxter, GlaxoSmithKline plc, and Acrux Limited among others.
Key SegmentBy Product Type, By Application, and By Region
Major Regions CoveredNorth America, Europe, Asia Pacific, Latin America, and the Middle East &, Africa
Purchase OptionsRequest customized purchase options to meet your research needs. Explore purchase options

Transmucosal Drug Delivery Devices Market: Segmentation Analysis

The global market for transmucosal drug delivery devices can be broken down into distinct submarkets delineated by product type, application, and geographic location.

The buccal route, the rectal route, and the nasal route are the three subsets that make up the overall market for pharmaceuticals around the world. Over the course of the projection period, it is anticipated that the buccal route segment will have the majority share of the market. As a direct result of the constant research and development that is being conducted in this field, buccal medicine administration systems have a very high potential for expansion. Especially among elderly people, the buccal delivery method is considered as more feasible and preferable than the oral dosing type.

This technique of drug delivery ensures that the first-pass metabolism will not be carried out, which paves the way for the effective administration of medications that are pH-sensitive and easily broken down. The increasing popularity of buccal drug administration can be linked to a number of benefits, including faster absorption, lower biofluid interaction, fewer adverse effects, high concentration availability at the target region, and shorter treatment regimes. In addition, these benefits can be attributed to the fact that there are fewer side effects. As a result, fueling the expansion of the segment over the course of the anticipated period.

The market for transmucosal medication delivery devices can be broken down into the hospital sector and the residential sector according to the application. Over the course of the projected period, it is anticipated that the hospital segment will seize a sizeable portion of the market share. The growth of this sector can be attributed to a number of factors, including an increase in hospital admissions, most notably of elderly patients, an abundance of emergency care supplies, and the development of new products and research conducted by a number of community hospitals. Research conducted in a variety of healthcare facilities yields novel insights and improves the formulation's potential for commercial application.

Experiments in vitro and in vivo were carried out in the year 2020 at three community hospitals located in Japan for the purpose of developing mucoadhesive microparticle-laden gels for the treatment of oral mucositis. The results indicate that the high concentration of the medication at the desired site along with the speedy treatment, in comparison to the more traditional dose forms, are likely to enhance acceptance. Insulin, powerful analgesics, and drugs for the treatment of heart failure are all components of buccal mucoadhesive formulations, which are now being researched and developed by a large number of hospitals located in nations with high levels of revenue. As a result, it is anticipated that this will serve as a driving force behind the growth of the category throughout the course of the projection year.

The global Transmucosal Drug Delivery Devices market is segmented as follows:

By Product Type

  • Buccal Route
  • Rectal Route
  • Nasal Route

By Application

  • Hospital
  • Residential

Browse the full “Transmucosal Drug Delivery Devices Market By Product Type (Buccal Route, Rectal Route, And Nasal Route), By Application (Hospital And Residential) And By Region - Global And Regional Industry Overview, Market Intelligence, Comprehensive Analysis, Historical Data, And Forecasts 2023 – 2030" Report At https://www.zionmarketresearch.com/report/transmucosal-drug-delivery-devices-market

Competitive Landscape

Some of the main competitors dominating the global Transmucosal Drug Delivery Devices market include - 

  • Abbott
  • Bayer AG
  • Teva Pharmaceutical Industries Ltd.
  • Slan Medicinal Holdings LTD
  • MMB Healthcare LLC.
  • BioDelivery Sciences International Inc.
  • Mylan N.V.
  • Novartis AG
  • Bristol-Myers Squibb Company
  • Johnson & Johnson Private Limited
  • Antares Pharma
  • BD
  • 3M
  • Pfizer Inc.
  • Boehringer Ingelheim International GmbH
  • Endo International plc
  • Echo Pharmaceuticals B.V.
  • B. Braun Melsungen AG
  • Baxter
  • GlaxoSmithKline plc
  • Acrux Limited

 Key Insights from Primary Research:

  • According to the analysis shared by our research forecaster, the Transmucosal Drug Delivery Devices market is likely to expand at a CAGR of around 6.2% during the forecast period (2023-2030).
  • In terms of revenue, the Transmucosal Drug Delivery Devices market size was valued at around US$ 41.2 billion in 2022 and is projected to reach US$ 68.1 billion by 2030.
  • The global Transmucosal Drug Delivery Devices market is being driven by the increasing prevalence of chronic diseases including cancer and cardiovascular disease.
  • Based on the product type, the buccal route segment is expected to dominate the market over the forecast period.
  • Based on the application, the hospital segment is expected to capture a significant market share over the forecast period.
  • Based on region, North America is expected to dominate the market over the forecast period.

Have Any Query? Ask Our Experts: https://www.zionmarketresearch.com/inquiry/transmucosal-drug-delivery-devices-market

Key questions answered in this report:

  • What is the market size and growth rate forecast for Transmucosal Drug Delivery Devices industry?
  • What are the main driving factors propelling the Transmucosal Drug Delivery Devices Market forward?
  • What are the leading companies in the Transmucosal Drug Delivery Devices Industry?
  • What segments does the Transmucosal Drug Delivery Devices Market cover?
  • How can I receive a free copy of the Transmucosal Drug Delivery Devices Market sample report and company profiles?

Key Offerings:

  • Market Size & Forecast by Revenue | 2023−2030
  • Market Dynamics – Leading Trends, Growth Drivers, Restraints, and Investment Opportunities
  • Market Segmentation – A detailed analysis By Product Type, By Application, and By Region
  • Competitive Landscape – Top Key Vendors and Other Prominent Vendors

Request for Customization on this Report as per your requirements - https://www.zionmarketresearch.com/custom/7424

(We tailor your report to meet your specific research requirements. Inquire with our sales team about customising your report.)

Regional Analysis:

North America is expected to dominate the market over the forecast period
North America is expected to dominate the global transmucosal drug delivery devices market over the forecast period. The regional growth is ascribed to the growing prevalence of chronic disease along with the increasing geriatric population and the rising regulatory approvals. For instance, according to the National Institutes of Health, between 2020 and 2050, there will be a 61.11% increase in the number of Americans aged 50 and older, from 137.25 million to 221.13 million.
There will be 142.66 million people aged 50 and older in 2050 who have at least one chronic condition, up from 71.522 million in 2020, a 99.5% rise. Moreover, approximately 25% of persons in the US have two or more chronic illnesses, according to statistics from the International Journal of Environmental Research and Public Health (IJEPH). Age affects the prevalence of chronic diseases, and older persons are statistically more likely to have several chronic diseases. It is believed that age and lifestyle modifications both contribute to the elevated risks. Therefore, the aforementioned stats drive the market growth over the forecast period.

By Region

  • North America
    • U.S.
    • Canada
    • Rest of North America
  • Europe
    • France
    • UK
    • Spain
    • Germany
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Rest of Asia Pacific
  • The Middle East & Africa
    • Saudi Arabia
    • South Africa
    • Rest of the Middle East & Africa
  • Latin America
    • Brazil
    • Argentina
    • Rest of Latin America

To know an additional revised 2023 list of market players, request a brochure of the report: https://www.zionmarketresearch.com/requestbrochure/transmucosal-drug-delivery-devices-market

Browse Other Related Research Reports from Zion Market Research:

Video Surveillance As A Service (VSaaS) Market Size - By Product (IP-Based And Analog), By Component (Hardware, Software, And Services), By Application (Residential, Retail, Transportation, Government, Hospitality, And Industrial), And By Region- Global Industry Perspective, Comprehensive Analysis, And Forecast, 2020 – 2026: https://www.zionmarketresearch.com/report/video-surveillance-as-a-service-market

Virtual Mobile Infrastructure Market Size - By Component (Software And Services), By Enterprise Size (SMEs And Large Enterprises), By Industry Vertical (Banking, Financial Services & Insurance (BFSI), Information Technology (IT) & Telecom, Retail, Manufacturing, Government, Logistics, And Energy & Utilities), And By Region- Global Industry Perspective, Comprehensive Analysis, And Forecast, 2020 – 2026: https://www.zionmarketresearch.com/report/virtual-mobile-infrastructure-market

Downstream Processing Market By Product (Chromatography Systems, Filters, Evaporators, Centrifuges, Dryers, And Others), By Technique (Cell Disruption, Solid-Liquid Separation, Concentration, Purification By Chromatography And Formulation), By Application (Antibiotic Production, Hormone Production, Antibodies Production, Enzyme Production, And Vaccine Production), And By Region - Global And Regional Industry Overview, Market Intelligence, Comprehensive Analysis, Historical Data, And Forecasts 2022 – 2030: https://www.zionmarketresearch.com/report/downstream-processing-market

HDPE Nonwoven Market By Type (Dry-Laid Non-Woven, Airlaid Non-Woven, Spun-Bond Non-Woven, And Others), By Application (Agriculture, Medical, Printing, Cargo Covers, Building Envelopes, And Others) And By Region - Global And Regional Industry Overview, Market Intelligence, Comprehensive Analysis, Historical Data, And Forecasts 2022 – 2030: https://www.zionmarketresearch.com/report/hdpe-nonwoven-market

Biomimetic Plastic Materials Market By Type (Biodegradable Plastic And Self-Healing Plastic), By Application (Research Institutions, Consumer Electronics, Automotive, And Transport), And By Region - Global And Regional Industry Overview, Market Intelligence, Comprehensive Analysis, Historical Data, And Forecasts 2023 – 2030: https://www.zionmarketresearch.com/report/biomimetic-plastic-materials-market

Nonwoven Filter Media Market By Technology (Spun Bonding, Airlaid, Wetlaid, Meltblown, Needlepunch, And Others), By Form (Air Filtration And Liquid Filtration), By Application (Transportation, Water Filtration, HVAC, Food And Beverages, Healthcare, Manufacturing, Advanced Technology, And Hydrocarbon Processing) And By Region - Global And Regional Industry Overview, Market Intelligence, Comprehensive Analysis, Historical Data, And Forecasts 2022 – 2030: https://www.zionmarketresearch.com/report/nonwoven-filter-media-market

Pharmaceutical Filtration Market By Product (Membrane Filters, Prefilters & Depth Media, Single-Use Systems, Cartridges & Capsules, Filter Holders, Filtration Accessories, And Others), By System (Single-Use And Reusable), By Type (Sterile And Non-Sterile), By Technique (Microfiltration, Ultrafiltration, Crossflow Filtration, Nanofiltration, And Others), By Application (Final Product Processing, Raw Material Filtration, Cell Separation, Water Purification, And Air Purification), By Scale Of Operation (Manufacturing Scale, Pilot-Scale, And Research & Development Scale), And By Region – Global And Regional Industry Overview, Market Intelligence, Comprehensive Analysis, Historical Data, And Forecasts 2022 – 2030: https://www.zionmarketresearch.com/report/pharmaceutical-filtration-market

Marinades And Dressings Market By Type (Acidic Marinades, Dairy Marinades, And Enzymatic Marinades), By Application (Foodservice Industry And Household), And By Region - Global And Regional Industry Overview, Market Intelligence, Comprehensive Analysis, Historical Data, And Forecasts 2022 – 2030: https://www.zionmarketresearch.com/report/marinades-dressings-market

Potassium Citrate Market By Purity (Less Than 98.0%, 98%-99%, And Above 99%), By Application (Buffering Agent, Flavoring Agent, Stabilizer, Anti-Oxidation Agent, Emulsifier, Acidity Regulator, And Others), By End-Use Industry (Food & Beverages, Pharmaceutical, Cosmetics & Personal Care, Industrial, And Others) And By Region - Global And Regional Industry Overview, Market Intelligence, Comprehensive Analysis, Historical Data, And Forecasts 2022 – 2030: https://www.zionmarketresearch.com/report/potassium-citrate-market

Povidone Iodine Market By Form (Solution, Ointments, External Pads, Swabs, Spray, Surgical Scrubs, Eyedrops, And Others), By Concentration (0-5%, 6-10%, And Others), By Application (Antiseptic Agent, Skin Sterilization, Instrument Sterilization, Antimicrobial Agent, Disinfectant, Aquaculture, And Others), By End-Use Industry (Healthcare & Pharmaceuticals, Personal Care, Agrochemicals, Household & Commercial, And Others) And By Region - Global And Regional Industry Overview, Market Intelligence, Comprehensive Analysis, Historical Data, And Forecasts 2022 – 2030: https://www.zionmarketresearch.com/report/povidone-iodine-market

Anticoagulant Reversal Drugs Market By Product Type (Idarucizumab, Protamine, Prothrombin Complex Concentrates, Coagulation Factors, Phytonadione, Andexanet Alfa, And Others), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, And Online Pharmacy), And By Region - Global And Regional Industry Overview, Market Intelligence, Comprehensive Analysis, Historical Data, And Forecasts 2022 – 2030: https://www.zionmarketresearch.com/report/anticoagulant-reversal-drugs-market

Natural Language Processing (NLP) Market By Industry Vertical (Retail, Healthcare, Banking, High Tech & Telecom, Automotive & Transportation, Financial Services, Manufacturing, Media, And Others), By Enterprise Size (Large Enterprises And Small & Medium-Sized Enterprises), By Deployment (Cloud, On-Premises, And Hybrid), By Technology (Speech Analytics, Interactive Voice Responses, Text Analytics, Optical Character Recognition, And Image & Pattern Recognition), And By Region - Global And Regional Industry Overview, Market Intelligence, Comprehensive Analysis, Historical Data, And Forecasts 2022 – 2030: https://www.zionmarketresearch.com/report/natural-language-processing-market

Respiratory Diagnostics Market By Product & Services (Instruments And Devices, Assays And Reagents And Services And Software), By Test Type (Mechanical Test, Imaging Test, Traditional Diagnostics Test, And In-Vitro Diagnostics Test), By Disease (Tuberculosis, Asthma, Chronic Obstructive Pulmonary Disease (COPD), Lung Cancer, And Others), By End-User (Clinical Laboratories, Hospitals, Physician Clinics, Diagnostic Centers, Ambulatory Surgical Centers, Home Care Facilities, And Others) And By Region - Global And Regional Industry Overview, Market Intelligence, Comprehensive Analysis, Historical Data, And Forecasts 2022 – 2030: https://www.zionmarketresearch.com/report/respiratory-diagnostics-market

Road Haulage Market By Type (Domestic Road Haulage And International Road Haulage), By Vehicle Type (Light Commercial Vehicles And Heavy Commercial Vehicles), By Application (Mining & Construction, Healthcare, Oil & Gas, Retail, Food & Beverages, Manufacturing, And Automotive), And By Region - Global And Regional Industry Overview, Market Intelligence, Comprehensive Analysis, Historical Data, And Forecasts 2023 – 2030: https://www.zionmarketresearch.com/report/road-haulage-market

Glucose Biosensor Market By Technology (Electrochemical Biosensors, Optical Biosensors, Piezoelectric Biosensors, And Others), By End-Use (Hospitals, Home Care, Research Institutes, Diagnostic Centers, And Clinics), And By Region - Global And Regional Industry Overview, Market Intelligence, Comprehensive Analysis, Historical Data, And Forecasts 2022 – 2030: https://www.zionmarketresearch.com/report/glucose-biosensor-market

About Zion Market Research:

Zion Market Research is a leading market research organization offering industry expertise and scrupulous consulting services to clients for their business development. The reports and services offered by Zion Market Research are used by prestigious academic institutions, start-ups, and companies globally to measure and understand the changing international and regional business backgrounds.

Our client’s/customer’s conviction on our solutions and services has pushed us in delivering always the best. Our advanced research solutions have helped them in appropriate decision-making and guidance for strategies to expand their business.

Follow Us on LinkedIn: https://www.linkedin.com/company/zion-market-research/

Follow Us on Twitter: https://twitter.com/zion_research

Follow Us on Facebook: https://www.facebook.com/zionmarketresearch

Follow Us on Pinterest: https://www.pinterest.com/zionmarketresearch/

Follow Us on YouTube: https://youtu.be/Y0Yfi7N8zSs

Contact Us:

Zion Market Research
USA/Canada Toll Free: 1 (855) 465-4651
Newark: 1 (302) 444-0166
India: +91 7768 006 007, +91 7768 006 008
Skype no: +13479038971, +17187054574
Skype no. United Kingdom: +442032894158
Web: https://www.zionmarketresearch.com/

Blog: https://zmrblog.com/

Still, Looking for More Information? OR Want Data for Inclusion in Magazine, Case Study, or Media?

Email Directly Here with Detail Information: sales@zionmarketresearch.com